Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, phase I/II studies - Test2 - elhamkhani - TriplyDB

Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, phase I/II studies

Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, phase I/II studies

http://www.wikidata.org/entity/Q28241091

about

Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies The Burn Wound Microenvironment Palatogenesis and cutaneous repair: A two-headed coin Focus on collagen: in vitro systems to study fibrogenesis and antifibrosis state of the art.New molecular medicine-based scar management strategies Translational lessons from scarless healing of cutaneous wounds and regenerative repair of the myocardium.Extracellular matrix molecules: potential targets in pharmacotherapy.Calreticulin: non-endoplasmic reticulum functions in physiology and disease.Immune Components in Human Milk Are Associated with Early Infant Immunological Health Outcomes: A Prospective Three-Country Analysis.Therapeutic improvement of scarring: mechanisms of scarless and scar-forming healing and approaches to the discovery of new treatments A review of fetal scarless healing.Target-seeking antifibrotic compound enhances wound healing and suppresses scar formation in mice.Regenerative healing, scar-free healing and scar formation across the species: current concepts and future perspectives.Transforming growth factor Beta 3 is required for excisional wound repair in vivo Wound complications after cleft repair in children with Van der Woude syndrome.Cellular and Molecular Characteristics of Scarless versus Fibrotic Wound Healing.Medical therapy of stricturing Crohn's disease: what the gut can learn from other organs - a systematic review.Management of keloids and hypertrophic scars: current and emerging options.Digital imaging analysis to assess scar phenotype.The effect of nano-scale topography on keratinocyte phenotype and wound healing following burn injury Smoking and its effect on scar healing The role of the TGF-β family in wound healing, burns and scarring: a review Radiation damage and radioprotectants: new concepts in the era of molecular medicine Reversibility of Stricturing Crohn's Disease-Fact or Fiction?Potency of umbilical cord blood- and Wharton's jelly-derived mesenchymal stem cells for scarless wound healing An in vivo screen of secreted proteins identifies adiponectin as a regulator of murine cutaneous wound healing.The embrace device significantly decreases scarring following scar revision surgery in a randomized controlled trial.Molecular insights on the effect of TGF-β1/-β3 in human corneal fibroblasts TGF-β3 modulates the inflammatory environment and reduces scar formation following vocal fold mucosal injury in rats.Avotermin for the improvement of scar appearance: a new pharmaceutical in a new therapeutic area.Regulating inflammation using acid-responsive electrospun fibrous scaffolds for skin scarless healing.MicroRNA epigenetics: a new avenue for wound healing research.Exploring anti-TGF-β therapies in cancer and fibrosis.New strategies in clinical care of skin wound healing.Scarless integumentary wound healing in the mammalian fetus: molecular basis and therapeutic implications.Pharmacological treatment for keloids.Altered TGF-β signaling in fetal fibroblasts: what is known about the underlying mechanisms?Internet-based survey on current practice for evaluation, prevention, and treatment of scars, hypertrophic scars, and keloids.Expression of TGF-β3 in isolated fibroblasts from foreskin.Useful strategies to prevent severe stricture after endoscopic submucosal dissection for superficial esophageal neoplasm

P2860

Q24595036-2FDC926C-5233-4477-9366-46476DFF92AF Q26753839-27B1106C-C5CC-41C7-802C-440EEAA49FA8 Q26823939-FE02AF21-0A12-43EF-B94C-D14DDFB1818D Q33518024-2D385CC8-4C64-4F57-AA13-D58A8648A0E7 Q33560989-1ACEBCEA-2D6A-413C-826B-DE6C7E2C9E17 Q33665506-39CBEF2C-4D66-46CE-9060-FDFF25EA75F0 Q33694487-9F4AF01B-A9A4-4503-8883-CCBD92C99788 Q33694634-F2900DCC-F979-44BF-B5FB-9D2A3F61ED2C Q33851756-63407639-BB0D-42A8-BC27-92128889BDC3 Q34089270-B8D50C54-2F5C-4560-998F-CB3C497006DE Q34279592-EC0E5574-88EB-46B9-89AA-B5B91A8CAB8D Q34411532-A4AE5D42-4FE4-4A3D-A368-93EF5595B642 Q34421454-E7C29726-198E-48C8-B684-5416986DDCF0 Q34460888-56FA6C52-922C-4260-8819-1A9F8AF94223 Q34479458-B85F49E4-F726-4109-8169-D173F29FF859 Q34495388-FA4E9A20-B3E6-4AA1-AB4F-D533EBFAB012 Q34504710-67924997-A997-4E36-832F-A46F3CFA7015 Q34699606-8B2BB852-5C9F-4300-87F9-78BCD0F5B377 Q35545263-115AB403-00DB-473F-9DC3-F9CBB7802BC9 Q35855715-6CEB6346-D00C-4B71-96A2-6D5661718E11 Q35962998-F67938AF-D595-407D-9B0E-8CF810DC7D96 Q36154247-696FFD56-CF2D-49E2-A9A4-5481164F8E1D Q36364394-4615AE4E-B6FB-4313-9502-2CE1425C1979 Q36373253-A8E949B6-C422-4B13-95C5-9FBD9DA64869 Q36427812-9B29D7FE-319A-40FF-92F6-E578D3ECCE85 Q36610006-67EBFDE6-9C69-4E70-8D58-B2E1C7173BC8 Q36920761-ECEDF328-F838-4201-A8C8-B369BB30DADF Q36971143-CE837453-2068-4F57-9F80-BAA871765C7B Q37438508-84C1C98C-53DF-4ABD-A2BE-D709F02935B1 Q37551928-3226083A-57C8-4256-9000-DDB50B8FB755 Q37699949-AACB88AF-0A5C-49B0-AEB5-7C0C4A551544 Q37827484-48505D7A-58AF-4FFA-96CC-0FDA35D7B8EE Q37896073-0EF3077E-94E5-450F-ACE2-EFBEEA9B5A20 Q38026467-E360E342-CB51-47CF-9306-9B4E9A0348AD Q38056453-B56969CD-AF81-40CD-A1B8-5205B3C6EE28 Q38128386-DD265DC2-A15E-4CC3-8284-8D7A41707E02 Q38153465-BCCCAEF3-38E9-4392-8D32-B119A4901F6A Q38231660-18CA0A96-55DF-45AE-8C72-7315CDA90A68 Q38533473-5E8CEF5D-A590-436D-A6BE-246E44DBC2ED Q38537513-E1835424-BA3A-4843-8855-E8AECDBB5BB8

P2860

Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, phase I/II studies

http://www.wikidata.org/entity/Q28241091

description

2009 nî lūn-bûn

@nan

2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Prophylactic administration of ...... controlled, phase I/II studies

@ast

Prophylactic administration of ...... controlled, phase I/II studies

@en

Prophylactic administration of ...... controlled, phase I/II studies

@nl

type

label

Prophylactic administration of ...... controlled, phase I/II studies

@ast

Prophylactic administration of ...... controlled, phase I/II studies

@en

Prophylactic administration of ...... controlled, phase I/II studies

@nl

prefLabel

Prophylactic administration of ...... controlled, phase I/II studies

@ast

Prophylactic administration of ...... controlled, phase I/II studies

@en

Prophylactic administration of ...... controlled, phase I/II studies

@nl

P1433

Q28241091-7D8E09F1-9653-40E2-9EB1-025C14BAABCE

P1476

Q28241091-C6E2031E-9DD1-4637-9BF3-7DAB63AEDF77

P2093

Q28241091-26810338-3B76-4C27-8AFA-8BA15C902641

Q28241091-26C3560C-3DE2-4DD2-8E4C-EAA095AC6880

Q28241091-2D463603-47C1-49C1-B9DE-E0999A9BE5BD

Q28241091-375F2881-7ADB-41BF-9BBA-9DB546D2BDCB

Q28241091-41275524-BDAE-4680-9C11-D55DB347DB19

Q28241091-4B5344A1-2703-4544-AF71-76731E823D72

Q28241091-7A6FCF6E-468F-4E31-A2AB-31C9DD72349E

Q28241091-7C044607-2C7F-4A79-AB64-6D8A11A190A1

Q28241091-93FDE82A-7510-4094-A227-F31A67358378

Q28241091-A001FA78-F387-4996-A38E-B9BA3386F35E

P304

Q28241091-1F703598-1919-4433-99B6-63748FD07E74

P31

Q28241091-22A928EC-D1C1-4378-BF8B-1498149D8EE9

P356

Q28241091-55D2A0B3-7E69-4843-A4C9-08C977AA1181

P407

Q28241091-7EB29A3C-9263-49D2-BE5E-E1F4D5E364E9

P433

Q28241091-771DB540-4675-486C-B8D6-63674820796B

P478

Q28241091-BE3907FB-103E-45F5-AF53-795E5E983478

P50

Q28241091-73D33722-38EE-458A-9C88-6983A51533AC

P577

Q28241091-343BB272-E2F6-45E4-910F-B3AF2C530158

P698

Q28241091-8557236B-E2CF-483E-A31C-03258A577D49

P921

Q28241091-816B73DD-4992-4D16-A2D9-64913681EBA3

P356

S0140-6736(09)60322-6

P1433

P1476

Prophylactic administration of ...... controlled, phase I/II studies

@en

P2093

Abdul Sattar

http://www.w3.org/2001/XMLSchema#string

Anna Ludlow

http://www.w3.org/2001/XMLSchema#string

Gaynor James

http://www.w3.org/2001/XMLSchema#string

Hugh Laverty

http://www.w3.org/2001/XMLSchema#string

James Bush

http://www.w3.org/2001/XMLSchema#string

Jeremy Bond

http://www.w3.org/2001/XMLSchema#string

Jonathan Duncan

http://www.w3.org/2001/XMLSchema#string

Jonquille Chantrey

http://www.w3.org/2001/XMLSchema#string

Karen So

http://www.w3.org/2001/XMLSchema#string

Lisa Taylor

http://www.w3.org/2001/XMLSchema#string

P304

1264-1274

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0140-6736(09)60322-6

http://www.w3.org/2001/XMLSchema#string

P407

P433

9671

http://www.w3.org/2001/XMLSchema#string

P478

373

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19362676

http://www.w3.org/2001/XMLSchema#string

P921